Loss of Codiak BioSciences under GAAP for 9 months of 2020 amounted to $73,708 million, an increase of 30.9% compared to $56,322 million in the previous year. Revenue increased 5.4 times to $1.275 million against $0.238 million a year earlier.
Loss of Codiak BioSciences under GAAP for 9 months of 2020 amounted to $73,708 million, an increase of 30.9% compared to $56,322 million in the previous year. Revenue increased 5.4 times to $1.275 million against $0.238 million a year earlier. 
ir.codiakbio.com
English (US) 